Clinical Trials Browser

Terminated × Has results × Advanced Solid Tumors × Clear all

NCT04074759 2025-01-23

FPT155-001

Phase 1 Terminated

80 enrolled 49 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03854227 2025-01-13

A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors

Phase 1 Terminated

54 enrolled 42 charts

Other solid neoplasm

Advanced Solid Tumors

NCT05394350 2024-11-08

MK-1088-002

Phase 1/2 Terminated

27 enrolled 19 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03379259 2024-10-26

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

Phase 1/2 Terminated

39 enrolled 29 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02994953 2024-09-20

COMBO

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

NCT04747470 2024-09-03

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

Phase 1 Terminated

13 enrolled 18 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03461952 2024-02-22

NIMBLe

Phase 2 Terminated

4 enrolled 4 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03954704 2023-11-21

Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors

Phase 1 Terminated

22 enrolled 19 charts

Other solid neoplasm

Advanced Solid Tumors

NCT04049617 2022-10-06

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors

Phase 1 Terminated

18 enrolled 17 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02880371 2022-06-16

A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Terminated

82 enrolled 32 charts

Other solid neoplasm

Advanced Solid Tumors

NCT01433991 2021-06-08

A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Phase 1/2 Terminated

30 enrolled 42 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02253992 2020-10-05

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Phase 1/2 Terminated

232 enrolled 17 charts

LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT03065023 2019-07-30

MK-4621-001

Phase 1/2 Terminated

15 enrolled 23 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00632424 2016-03-10

Phase 1 Trial of Oral Ixabepilone

Phase 1 Terminated

23 enrolled 11 charts

Other solid neoplasm

Advanced Solid Tumors

NCT01004822 2015-11-20

A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

Phase 1 Terminated

31 enrolled 20 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00932126 2015-10-28

This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors

Phase 1 Terminated

35 enrolled 6 charts

Other solid neoplasm

Advanced Solid Tumors